Abstract
Topical antimicrobials and antiseptics are used perioperatively to reduce the ocular surface bacteria flora (OSBF) that are involved in the development of post‐operative infectious complications. However, their effectiveness is still a controversial topic. This systematic review, performed according to the PRISMA guidelines and registered in PROSPERO, aims to provide an overview of the efficacy of the agents currently used in peri‐cataract surgery and ‐intravitreal injections (IVI) in lowering the OSBF. Although effective in lowering OSBF, perioperative topical antimicrobials are associated with the risk of resistance development, with no obvious additional benefit compared with topical antisepsis. Conversely, the effectiveness of topical antiseptics before cataract surgery and IVI is strongly supported. Based on the available evidence, perioperative antimicrobials are not recommended, whereas the perioperative use of antiseptics is strongly recommended as prophylactic treatment for lowering the infection due to OSBF. Post‐operative antimicrobials may be considered in eyes at higher risk for infection.
Original language | English |
---|---|
Journal | Acta ophthalmologica |
Early online date | 10 Jul 2023 |
DOIs | |
Publication status | Early online date - 10 Jul 2023 |
Keywords
- intravitreal injections
- ocular surface bacterial flora
- topical antiseptics
- cataract surgery
- topical antimicrobials